Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto

1 6 Compounds having activity as inhibitors of IKK are disclosed, particularly IKK-2. The compounds of this invention are anilinopyrimidine derivatives having the following structure: wherein Rand Rare as defined herein. Such compounds have utility in the treatment of a wide range of conditions that...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Kois, Adam, MacFarlane, Karen J, Satoh, Yoshitaka, Bhagwat, Shripad S, Parnes, Jason S, Palanki, Moorthy S. S, Erdman, Paul E
Format:	Patent
Sprache:	eng
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	Kois, Adam MacFarlane, Karen J Satoh, Yoshitaka Bhagwat, Shripad S Parnes, Jason S Palanki, Moorthy S. S Erdman, Paul E
description	1 6 Compounds having activity as inhibitors of IKK are disclosed, particularly IKK-2. The compounds of this invention are anilinopyrimidine derivatives having the following structure: wherein Rand Rare as defined herein. Such compounds have utility in the treatment of a wide range of conditions that are responsive to IKK inhibition. Thus, methods of treating such conditions are also disclosed, as are pharmaceutical compositions containing one or more compounds of the above compounds.
format	Patent
fullrecord	<record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_07442699</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>07442699</sourcerecordid><originalsourceid>FETCH-uspatents_grants_074426993</originalsourceid><addsrcrecordid>eNqNykEKwjAQQNFuXIh6h7mAIFqULkUUpVuXgkQzNgPJTMiMBW9vRQ_g6sPjj6vLlikSS34VSuSJETwW6p1RjwpO4dS2QBzoRiZlEPZwl5RFyUj4CwktiFcoGJ2hBwtY0GRajR4uKs5-nVRw2J93x_lT8_Cx6bUr7pPFpq6X66ZZ_bG8AcaNPXg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto</title><source>USPTO Issued Patents</source><creator>Kois, Adam ; MacFarlane, Karen J ; Satoh, Yoshitaka ; Bhagwat, Shripad S ; Parnes, Jason S ; Palanki, Moorthy S. S ; Erdman, Paul E</creator><creatorcontrib>Kois, Adam ; MacFarlane, Karen J ; Satoh, Yoshitaka ; Bhagwat, Shripad S ; Parnes, Jason S ; Palanki, Moorthy S. S ; Erdman, Paul E ; Signal Pharmaceuticals, LLC</creatorcontrib><description>1 6 Compounds having activity as inhibitors of IKK are disclosed, particularly IKK-2. The compounds of this invention are anilinopyrimidine derivatives having the following structure: wherein Rand Rare as defined herein. Such compounds have utility in the treatment of a wide range of conditions that are responsive to IKK inhibition. Thus, methods of treating such conditions are also disclosed, as are pharmaceutical compositions containing one or more compounds of the above compounds.</description><language>eng</language><creationdate>2008</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7442699$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,802,885,64039</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7442699$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Kois, Adam</creatorcontrib><creatorcontrib>MacFarlane, Karen J</creatorcontrib><creatorcontrib>Satoh, Yoshitaka</creatorcontrib><creatorcontrib>Bhagwat, Shripad S</creatorcontrib><creatorcontrib>Parnes, Jason S</creatorcontrib><creatorcontrib>Palanki, Moorthy S. S</creatorcontrib><creatorcontrib>Erdman, Paul E</creatorcontrib><creatorcontrib>Signal Pharmaceuticals, LLC</creatorcontrib><title>Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto</title><description>1 6 Compounds having activity as inhibitors of IKK are disclosed, particularly IKK-2. The compounds of this invention are anilinopyrimidine derivatives having the following structure: wherein Rand Rare as defined herein. Such compounds have utility in the treatment of a wide range of conditions that are responsive to IKK inhibition. Thus, methods of treating such conditions are also disclosed, as are pharmaceutical compositions containing one or more compounds of the above compounds.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2008</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNqNykEKwjAQQNFuXIh6h7mAIFqULkUUpVuXgkQzNgPJTMiMBW9vRQ_g6sPjj6vLlikSS34VSuSJETwW6p1RjwpO4dS2QBzoRiZlEPZwl5RFyUj4CwktiFcoGJ2hBwtY0GRajR4uKs5-nVRw2J93x_lT8_Cx6bUr7pPFpq6X66ZZ_bG8AcaNPXg</recordid><startdate>20081028</startdate><enddate>20081028</enddate><creator>Kois, Adam</creator><creator>MacFarlane, Karen J</creator><creator>Satoh, Yoshitaka</creator><creator>Bhagwat, Shripad S</creator><creator>Parnes, Jason S</creator><creator>Palanki, Moorthy S. S</creator><creator>Erdman, Paul E</creator><scope>EFH</scope></search><sort><creationdate>20081028</creationdate><title>Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto</title><author>Kois, Adam ; MacFarlane, Karen J ; Satoh, Yoshitaka ; Bhagwat, Shripad S ; Parnes, Jason S ; Palanki, Moorthy S. S ; Erdman, Paul E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_074426993</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2008</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Kois, Adam</creatorcontrib><creatorcontrib>MacFarlane, Karen J</creatorcontrib><creatorcontrib>Satoh, Yoshitaka</creatorcontrib><creatorcontrib>Bhagwat, Shripad S</creatorcontrib><creatorcontrib>Parnes, Jason S</creatorcontrib><creatorcontrib>Palanki, Moorthy S. S</creatorcontrib><creatorcontrib>Erdman, Paul E</creatorcontrib><creatorcontrib>Signal Pharmaceuticals, LLC</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Kois, Adam</au><au>MacFarlane, Karen J</au><au>Satoh, Yoshitaka</au><au>Bhagwat, Shripad S</au><au>Parnes, Jason S</au><au>Palanki, Moorthy S. S</au><au>Erdman, Paul E</au><aucorp>Signal Pharmaceuticals, LLC</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto</title><date>2008-10-28</date><risdate>2008</risdate><abstract>1 6 Compounds having activity as inhibitors of IKK are disclosed, particularly IKK-2. The compounds of this invention are anilinopyrimidine derivatives having the following structure: wherein Rand Rare as defined herein. Such compounds have utility in the treatment of a wide range of conditions that are responsive to IKK inhibition. Thus, methods of treating such conditions are also disclosed, as are pharmaceutical compositions containing one or more compounds of the above compounds.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng
recordid	cdi_uspatents_grants_07442699
source	USPTO Issued Patents
title	Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T20%3A26%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Kois,%20Adam&rft.aucorp=Signal%20Pharmaceuticals,%20LLC&rft.date=2008-10-28&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E07442699%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true